Resources

Past Presentation

Questions about Metformin Recall | June 11, 2020

Date of Presentation: June 11, 2020

Type: Past Presentation  

Audience: Clinical  

Program: Diabetes ECHO Program  

Keywords: #metformin  #metformin recall  

The FDA recently alerted patients and health care professionals to nitrosamine impurity findings in certain metformin extended-release products. As clinicians continue to receive questions about the recent FDA alert, Dr. Mary Carol Greenlee, practitioner at Western Slope Endocrinology in Grand Junction, Colorado, shares information about what I/T/U providers and educators need to know.

 

Recording:

Presented by:

Dr. Mary Carol Greenlee

Mary Carol Greenlee, MD, FACP, FACE, is board certified in Internal Medicine and Endocrinology, Diabetes and Metabolism and is in private practice at Western Slope Endocrinology in Grand Junction, Colorado. She is currently serving on the Endocrine Society Council after several years on the Society’s Clinical Affairs Core Committee. She has a special interest in care delivery issues and has been actively involved with the collaborative project sponsored by the Endocrine Society to develop tools to assist with transition from pediatric to adult care for patients with endocrine disorders.

Resources Provided:

Date added: June 11, 2020